🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#SHAPE trial 🌟simple hysterectomy for early stage #cervicalcancer 🌟simple vs radical hyst 1A2-1B1 (<2cm) confirms non-inferiority of a 3yr pelvic recurrence rate and secondary endpts PFS/OS are met OncoAlert SoMe4GynOnc IJGC

Hot off the presses!🔥📰 National Comprehensive Cancer Network (NCCN) Ovarian Cancer Guidelines endorse oxaliplatin-based regimens like docetaxel/oxali/bevacizumab (Teaco trial) in special circumstances (i.e. chemo shortages💉). Thank u Dr. Deb Armstrong & team for supporting the SGO FdtnForWomensCancer The GOG Foundation Inc. ASCO recs.👏

🚨Another practice-changing study at #ASCO23 🌟DUO-O/The GOG Foundation Inc. 3025 demonstrates improved progression free survival in pts w/ HR deficient AND proficient advanced stage #OvarianCancer treated with durvalumab + olaparib + bevacizumab #gyncsm #ImmunoOnc

3rd #ADC on the U.S. FDA trajectory??Promising Phase 1 data of Luvelta targeting FOLRalpha platinum-resistant ovarian cancer were randomized in 1:1 to lower/higher dosing with ORR of 31.7% in FOLR agnostic population and 37.5% in TPS>25% #MoffittASCO23 #ASCO23 Moffitt Cancer Center

#ASCO2023 wow- OS data confirms lasting benefit! New results from the MIRASOL trial. Congratulations Dr Moore. So rare to see PFS and OS Hazard Ratio of the same magnitude in gynecological cancer. #gyncsm

👀this is the FIRST TRIAL to show overall survival benefit in platinum resistant #OvarianCancer. 🙌Standard of care is clear! 🧐Get the FOLR1 testing and identify the patients that will benefit from mirvetuximab #ASCO23 #gyncsm

#ASCO23🧵 highlighting the amazing work by our MD Anderson Cancer Center #oncsurgery #GynOnc fellows. 🙌These trainees are going to change the #gyncsm world and #endcancer

🤔 Naomi Adjei, MD, MPH, MSEd presented thought provoking data regarding uptake of upfront maintenance therapy in #OvarianCancer - understanding the disparities in use of #PARPi +/- bevacizumab is essential to improve outcomes for our patients #ASCO23 #gyncsm

💡Jeffrey How presented an intriguing trial in progress in collaboration with mentor Amir Jazaeri exploring use of lenvatinib and pembrolizumab in recurrent #OvarianCancer #ASCO23 #gyncsm #ImmunoOnc

🔪 Anne Knisely, MD demonstrated that identification of #MRD at second look laparoscopy in #OvarianCancer is associated with worse survival outcomes #ASCO23 #gyncsm

🤯Exciting data for GYN Cancer | #GYNCSM presented at #ASCO23 DT session by MD Anderson Cancer Center Dr. Funda Meric-Bernstam! 🎯DESTINY Pan-Cancer demonstrated activity of T-DXd (#AntibodyDrugConjugate) across multiple #HER2 ➕tumors 👍especially #EndometrialCancer #CervicalCancer & #OvarianCancer

Thank you Shannon Westin, MD, MPH, FASCO and David S. Hong MD for your mentorship and Conquer Cancer, the ASCO Foundation and Eisai Oncology Medical for the endowed merit award! We are honored to share our work on RAS mutation in gyn cancer patients, which may help patient selection and future trial design #ASCO23 #gyncsm

Our Amazing Dr Son! Watch her! She will become a future superstar!

Beating the Texas 🔥 with #teambuilding and #tacos with our amazing MD Anderson Cancer Center Gyn Onc fellows and graduates! Jeffrey How Han T. Cun Roni Nitecki Wilke Aaron Shafer

Our Chief Patient Experience Officer Dr. Michael Frumovitz's story reflects MD Anderson Cancer Center' profound impact based on his personal journey as a patient. Thank you, Michael Frumovitz, for your honesty, for your determination and for your unwavering dedication to our patients. #EndCancer

Fine tuning these superstar’s concepts with clinical trial design experts today. @emilydressler stastistician extraordinaire is AMAZING!! ⁩ Your trainees are in great hands ⁦Shannon Westin, MD, MPH, FASCO⁩ ⁦Neil Iyengar, MD⁩ ⁦Amanda Nickles Fader, MD⁩ ⁦AACR⁩ ⁦ASCO⁩ #MCCR23

Y’all, meet all my new friends who happen to also be the future of clinical research in oncology & hematology!!! ASCO AACR #MCCR23 #unVAILed

An inspirational message Michael Frumovitz MD Anderson Cancer Center, we applaud your bravery, courage, strength, and passion always 💜 #SGOMtg #FrumoFighters

Thank you for highlighting our work, and thank you to our patients who participated! Honored to receive the Eisai endowed merit award with mentorship from Shannon Westin, MD, MPH, FASCO. ASCO Conquer Cancer, the ASCO Foundation Eisai US

Our. Fellows. Rock!!! MD Anderson Cancer Center GYN ONC fellows presenting novel #ClinicalTrials at #ASCO25 Ji (Jessica) Son - phase 1 trial of etiglimab and nivolimab in clear cell #OvarianCancer